Media Coverage

The New York Times 0

Scientists have long suspected that PAI-1 has other functions outside of clotting that relate to aging. Dr. Douglas Vaughan, a cardiologist at Northwestern medical school, noticed, for example, that mice that had been genetically engineered to produce high levels of the protein age fairly quickly, going bald and dying of heart attacks at young ages. People who have higher levels of the protein in their bloodstreams also tend to have higher rates of diabetes and other metabolic problems and to die earlier of cardiovascular disease.

TODAY 0

Margaret and Mark Zumdahl have made countless memories during their 25-year marriage, but Margaret, who lives with Alzheimer’s, is slowly starting to lose those memories. Thanks to a special program at Northwestern’s Cognitive Neurology and Alzheimer’s Disease Center, the couple is receiving help to deal with the disease.

U.S. News & World Report 0

The number of U.S. children allergic to peanuts has increased by 21 percent since 2010, with nearly 2.5 percent of youngsters now having this type of allergy, a new study has found. “According to our data, the risk of peanut allergy was nearly double among black children relative to white children,” study co-author Christopher Warren said in a news release from the college. Study lead author Dr. Ruchi Gupta
acknowledged that peanut and other food allergies can be “very challenging for children and families,” but “the good news is that parents now have a way to potentially prevent peanut allergy by introducing peanut products to infants early after assessing risk with their pediatrician and allergist.” Both Gupta and Warren are researchers from Northwestern University’s Feinberg School of Medicine in Chicago.

Wall Street Journal 0

“Crispr editing of RNA creates more opportunities for things we can do therapeutically,” says Elizabeth McNally , director of the Center for Genetic Medicine at Northwestern University’s Feinberg School of Medicine, who wasn’t involved in the study but is working on efforts to use the Crispr system to treat forms of muscular dystrophy and other conditions.

Events